Temsirolimus

Information about Temsirolimus

Temsirolimus uses

Temsirolimus is used in kidney cancer.

How temsirolimus works

Temsirolimus suppresses the activity of body's immune system and prevents rejection of the transplanted organ.

Common side effects of temsirolimus

Nausea, Vomiting, Insomnia (difficulty in sleeping), Rash, Headache, Reduced blood platelets, Breathlessness, Fatigue, Bacterial infection, Decreased white blood cell count, Decreased potassium level in blood, Increased glucose level in blood, Cough, Viral infection, Diarrhoea, Stomatitis (Inflammation of the mouth), Constipation, Altered taste, Decreased white blood cell count (neutrophils).

Available Medicine for Temsirolimus

  • ₹70971
    Pfizer Ltd
    1 variant(s)

Expert advice for Temsirolimus

  • Temsirolimus contains high levels of alcohol and should be taken with caution if you take alcohol in large quantities or if you have to drive or operate heavy machinery

Frequently asked questions for Temsirolimus

Temsirolimus

Q. Is temsirolimus a chemotherapy agent?
Yes, temsirolimus is a chemotherapy agent and is used in the treatment of certain types of cancers like kidney cancer and mantle cell lymphoma (a type of cancer of lymph nodes immune cells
Q. Is temsirolimus cytotoxic, a kinase inhibitor?
Yes, temsirolimus is cytotoxic and kinase inhibitor
Q. Is temsirolimus a vesicant?
Temsirolimus is not a vesicant (irritant) drug
Show More
Q. What is temsirolimus used for?
Temsirolimus is used to treat advanced kidney cancer and previously treated mantle cell lymphoma (a type of lung cancer affecting lymph nodes)
Q. How does temsirolimus work?
Temsirolimus works by inhibiting a human protein chemical called mammalian target of rapamycin (mTOR) thereby blocking tumor or cancer growth.

Content on this page was last updated on 27 March, 2017, by Dr. Varun Gupta (MD Pharmacology)